Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

The high resolution crystal structure for class A beta-lactamase PER-1 reveals the bases for its increase in breadth of activity.

Tranier S, Bouthors AT, Maveyraud L, Guillet V, Sougakoff W, Samama JP.

J Biol Chem. 2000 Sep 8;275(36):28075-82.

2.

Site-directed mutagenesis of residues 164, 170, 171, 179, 220, 237 and 242 in PER-1 beta-lactamase hydrolysing expanded-spectrum cephalosporins.

Bouthors AT, Delettré J, Mugnier P, Jarlier V, Sougakoff W.

Protein Eng. 1999 Apr;12(4):313-8.

PMID:
10325401
3.

Novel OXA-10-derived extended-spectrum beta-lactamases selected in vivo or in vitro.

Mugnier P, Casin I, Bouthors AT, Collatz E.

Antimicrob Agents Chemother. 1998 Dec;42(12):3113-6.

4.

Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate.

Bouthors AT, Jarlier V, Sougakoff W.

J Antimicrob Chemother. 1998 Sep;42(3):399-401. No abstract available.

PMID:
9786485
5.

Role of residues 104, 164, 166, 238 and 240 in the substrate profile of PER-1 beta-lactamase hydrolysing third-generation cephalosporins.

Bouthors AT, Dagoneau-Blanchard N, Naas T, Nordmann P, Jarlier V, Sougakoff W.

Biochem J. 1998 Mar 15;330 ( Pt 3):1443-9.

6.

OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.

Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P.

Antimicrob Agents Chemother. 1997 Oct;41(10):2188-95.

Supplemental Content

Loading ...
Support Center